Page 326 - Medicine and Surgery
P. 326

P1: FAW
         BLUK007-07  BLUK007-Kendall  May 25, 2005  18:18  Char Count= 0








                   322 Chapter 7: Nervous system


                   Huntington’s disease should be suspected. The family  Geography
                   history may be concealed or unknown.         The disease shows strong geographical variation, with
                                                                whites having twice the risk of non-whites and those
                                                                in higher latitudes (i.e. colder climates) having higher
                   Macroscopy/microscopy
                                                                risk.
                   Marked loss of small neurones in the caudate nucleus
                   and putamen.
                                                                Aetiology
                                                                There are several factors postulated.
                   Investigations
                                                                    It is thought that there is an abnormal immune re-
                   Genetic analysis is becoming available for pre-
                                                                  sponse, possibly triggered by an unknown viral anti-
                   symptomatictestingbutthisraisesanethicaldilemma,as
                                                                  gen.
                   there is no treatment. However, it is important, as many
                                                                    Genetic predisposition to the disease – monozygotic
                   young adults wish to know their status before embarking
                                                                  twins have a 20–40% concordance, whereas siblings
                   upon having a family.
                                                                  and dizygotic twins have a 3–5% risk.
                                                                  There is an association with HLA-A3, B7, DR2 and

                   Management                                     DR3.
                   No treatment arrests the disease but dopamine-blocking     Childhood exposure to some environmental factor –
                   drugs such as haloperidol and dopamine-depleting  migration before the age of 15 years leads to the risk
                   drugs such as tetrabenazine may help to control the  of MS becoming that of the new country.
                   chorea. Patients and their families should be offered ge-
                   netic testing and counselling where appropriate.
                                                                Pathophysiology
                                                                Discrete areas of demyelination called ‘plaques’ ranging
                   Prognosis                                    in size from a few millimetres to a few centimetres. They
                   There is a relentless progression of dementia and chorea  are often perivenous and common sites in the brain in-
                   with death usually occurring within 20 years from the  clude the optic nerve, around the lateral ventricles and
                   onset of symptoms.                           in the brainstem and cerebellar peduncles. The cervical
                                                                spinal cord is also commonly affected, but any part of
                                                                the central white matter may be involved. The myelin of
                                                                the peripheral nerves is not affected.
                    Multiple sclerosis
                                                                  Initial oedema around the soft patches of white matter
                                                                leads to symptoms that partially resolve as the oedema
                   Definition                                    subsides.
                   An immune-mediated disease characterised by discrete  The areas of demyelination are disseminated in time
                   areas of demyelination in the brain and spinal cord.  and place.


                   Incidence/prevalence                         Clinical features
                   About 60 per 100,000 in England.             There are several patterns of the course of MS.
                                                                  Relapsing-remitting MS affects about 20–30% of pa-

                                                                  tients,withlesions(andsymptomsandsigns)affecting
                   Age
                                                                  different areas of the CNS at different times, with full
                   Peak onset is between the ages of 25 and 40 years, un-
                                                                  or partial recovery between episodes, but no progres-
                   commonly presents over the age of 60.
                                                                  sion between.
                                                                  Primary-progressive MS affects 10–20% (particularly

                   Sex                                            older patients), the pattern is that of chronic progres-
                   Women slightly more than men (1.7:1).          sive deterioration from the time of onset.
   321   322   323   324   325   326   327   328   329   330   331